Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
IceCure Medical Ltd (NASDAQ: ICCM)
ICCM Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
99.50%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
400%
ICCM Stock Analysis
ICCM
PE Ratio:
ICCM
PEG Ratio:
Not Available
ICCM
Forward EPS Growth (12 month):
0.00%
ICCM
PS Ratio:
2.9
ICCM
PSG Ratio:
ICCM
Forward Revenue Growth (12 month):
104.10%
ICCM Articles
No data was found